Cargando…
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?
BACKGROUND AND AIMS: A third of patients with primary biliary cholangitis (PBC) experience poorly understood cognitive symptoms, with a significant impact on quality of life (QOL), and no effective medical treatment. Allopregnanolone, a neurosteroid, is a positive allosteric modulator of gamma-amino...
Autores principales: | Wetten, Aaron, Ogle, Laura, Mells, George, Hegade, Vinod S., Jopson, Laura, Corrigan, Margaret, Palmer, Jeremy, Johansson, Maja, Bäckström, Torbjörn, Doverskog, Magnus, Jones, David E. J., Dyson, Jessica K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747297/ https://www.ncbi.nlm.nih.gov/pubmed/36523650 http://dx.doi.org/10.1155/2022/3618090 |
Ejemplares similares
-
GR3027 reversal of neurosteroid-induced, GABA-A receptor-mediated inhibition of human brain function: an allopregnanolone challenge study
por: Johansson, Maja, et al.
Publicado: (2018) -
Extra-Synaptic GABA(A) Receptor Potentiation and Neurosteroid-Induced Learning Deficits Are Inhibited by GR3027, a GABA(A) Modulating Steroid Antagonist
por: Bengtsson, Sara K. S., et al.
Publicado: (2023) -
GR3027 antagonizes GABA(A) receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy
por: Johansson, Maja, et al.
Publicado: (2015) -
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
por: Jones, David E.J., et al.
Publicado: (2022) -
The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
por: Dyson, J. K, et al.
Publicado: (2016)